Back to Search
Start Over
Comparing the efficacy of field treatments for actinic keratosis: a critical appraisal of a randomized trial in the New England Journal of Medicine.
- Source :
- British Journal of Dermatology; Jun2020, Vol. 182 Issue 6, p1343-1344, 2p
- Publication Year :
- 2020
-
Abstract
- Summary: Aim: Jansen et al. conducted a randomized trial to compare the efficacy of four field treatments for actinic keratosis (AK). Setting and design: This was a multicentre, single‐blind, randomized trial conducted in the dermatology departments of four Netherlands hospitals. Patients were not blinded. The investigator who evaluated the trial outcome was blinded. Study exposure: This study included adult patients with at least five AKs on the face or vertex scalp. Patients were randomized to treatment with fluorouracil 5% cream, imiquimod 5% cream, methyl aminolaevulinate photodynamic therapy (MAL‐PDT) or ingenol mebutate 0·015% gel. Outcomes: The primary outcome was whether patients had ≥ 75% reduction in AK count 12 months after treatment. Results: In total 624 patients participated. The likelihood of having ≥ 75% reduction in AK count 12 months after treatment was significantly higher (twice as high or greater) for fluorouracil than for any other therapy. Approximately 75% of patients treated with fluorouracil experienced ≥ 75% reduction in AK count at 12 months. Conclusions: Jansen et al. conclude that 1 year after treatment, fluorouracil was significantly more effective at AK reduction than imiquimod, MAL‐PDT or ingenol mebutate. [ABSTRACT FROM AUTHOR]
- Subjects :
- ACTINIC keratosis
TREATMENT effectiveness
NEW trials
PHOTODYNAMIC therapy
Subjects
Details
- Language :
- English
- ISSN :
- 00070963
- Volume :
- 182
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- British Journal of Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 143548275
- Full Text :
- https://doi.org/10.1111/bjd.18537